Repro USMLE step 1 9-1 (3) Flashcards
The patient presents with sudden vaginal bleeding and painful abdominal cramps at 32 weeks’ gestation without trauma. She has low blood pressure and rapid heart rate indicating a bleed. The fetus is in distress within a hypertonic uterus. The patient’s history of smoking and cocaine use also point to a diagnosis of abruptio placentae, or placental abruption.
Placental abruption is the partial or complete premature separation of placenta from the uterine wall. Risk factors include smoking and cocaine use as seen in this patient, as well as trauma, hypertension, and preeclampsia. Patients present with sudden painful bleeding in the third trimester, as seen in the vignette. Complications are life threatening and include?
DIC from tissue factor entering maternal circulation, maternal shock, and fetal distress or death.
Postpartum hemorrhage and Sheehan syndrome are associated with placenta accreta/increta/percreta, where the maternal portion of the placenta, the desidua basalis, has abnormal attachment and separation after delivery. This condition would be visible on ultrasound, unlike what is seen in this patient. Preeclampsia is a condition of new-onset hypertension with?
either proteinuria or end-organ dysfunction after the 20th week of gestation. Abruptio placentae can be a complication of preeclampsia, but not a cause. This patient’s condition also does not include infertility as a complication.
Bleeding in the third trimester that is bright or dark red and associated with painful abdominal cramps suggests placental abruption. Placental abruption is the partial or complete premature separation of placenta form the uterine wall. Risk factors include smoking, cocaine use, trauma, hypertension, and preeclampsia. Complications include?
DIC, maternal shock, and fetal distress.
This patient’s genotype and the presence of male internal genitalia are suggestive of a genotypic male who was born with ambiguous genitalia due to?
a congenital 5a-reductase deficiency.
5a-Reductase converts testosterone to dihydrotestosterone (DHT), the potent androgen required for the development of male external genitalia in utero. Individuals with a congenital 5a-reductase deficiency are born with male internal genitalia (including testes) but ambiguous or female-appearing external genitalia, such that most are raised as girls. When they reach puberty, however, increasing testosterone levels cause ?
masculinization of the external genitalia, resulting in the “penis-at-12” phenomenon. 5a-Reductase deficiency thus causes an increased testosterone/DHT ratio; luteinizing hormone levels can be normal or elevated in patients with 5a-reductase deficiency.
17a-Hydroxylase deficiency leads to decreased sex hormone and cortisol levels with elevated mineralocorticoid levels. Tyrosinase deficiency presents with characteristics of albinism. Nicotinamide adenine dinucleotid phosphate oxidase deficiency is ?
characteristic of immune disorders. 21-Hydroxylase deficiency and aromatase deficiency present with male characteristics at birth.
5α-Reductase converts testosterone to DHT, which plays a critical role in male sexual development. Congenital 5α-reductase deficiency results in?
male internal genitalia (including testes) but ambiguous or female-appearing external genitalia. However, at puberty, increased testosterone levels cause masculinization of the external genitalia.
This patient presents with reduced libido, erectile dysfunction, and fatigue a few weeks after starting a new treatment for tinea cruris. He is also found to have reduced body hair and testicular volume, as well as gynecomastia. These signs and symptoms suggest testosterone deficiency. Diminished testosterone secretion in adults leads to decreases in libido, sexual hair, muscle mass, testicular volume, and energy. Ketoconazole, an antifungal drug used to treat tinea infections, directly inhibits?
testosterone biosynthesis, resulting in testosterone deficiency.
Leydig cells produce testosterone and are the only major cell type found in the interstitium surrounding the seminiferous tubules. Testosterone secreted by these cells is responsible for the maintenance of the seminiferous epithelium, and thus for spermatogenesis, as well as for the development of secondary sexual characteristics in males.
Although cells of the zona reticularis produce small amounts of testosterone, it is unlikely that reduced functioning would cause a large enough decrease in testosterone levels to cause the symptoms seen in this patient. Sertoli cells support and nourish developing sperm. Reduced function of Sertoli cells would result in ?
infertility due to impaired sperm production and decreased inhibin secretion, resulting in high follicle-stimulating hormone levels. Dysfunction of both spermatids and spermatozoa would also result in infertility, as opposed to symptoms of reduced libido and erectile dysfunction.
Antifungal drugs, such as ketoconazole, have been shown to interfere with testosterone synthesis in the Leydig cells of the testes, resulting in?
decreased testosterone levels. Leydig cells are the major producers of testosterone in males. A low testosterone level results in decreased libido, body hair, muscle mass, testicular volume, and energy.
This patient, who is currently undergoing chemotherapy, presents with vaginal burning, itching, and inflammation and the presence of a thick white discharge in the vagina. Gram staining of the discharge shows constrictions between rod-like cells along with globular buds, confirming a diagnosis of ?
Candida albicans vulvovaginitis.
C. albicans is a pathogenic yeast found in the vulva and vagina, which commonly causes opportunistic infections. Risk factors include immunosuppression, diabetes mellitus, antibiotic use, and contraceptive device use. Diagnosis can be made with microscopic observation of C. albicans on a wet mount or with Gram staining. The microscopic image provided shows constrictions (“pseudohyphae”) between rod-like C. albicans cells along with globular buds, which represent newly formed fungal cells that are still growing.
It is likely that Candida vulvovaginitis developed because this patient is undergoing chemotherapy, which results in a state of immunosuppression. Significantly, C. albicans can also cause ?
esophagitis in immunocompromised patients.
In particular, it is known to cause esophagitis in patients with HIV whose CD4+ cell count has dropped below 100/mm3.
Chronic lung disease resembling tuberculosis is suggestive of the presence of Histoplasma, not Candida, organisms. Lesions in lung cavities may be caused by Aspergillus fumigatus, but not Candida. Meningoencephalitis is a manifestation of Cryptococcus neoformans infection in immunocompromised individuals; it is not a known manifestation of Candida infection. Migrating synovitis is caused by infection with Neisseria gonorrhoeae, not Candida.
C. albicans is a yeast and common opportunistic pathogen. Vaginal itching with a whitish, curd-like discharge is suggestive of ?
C. albicans vulvovaginitis. Candida infection can also cause esophagitis in immunocompromised patients
This patient is likely suffering from benign prostatic hyperplasia (BPH), an enlargement of the prostate gland that affects one-third of men > 50 years old. BPH involves proliferation of the stromal and epithelial elements within the periurethral and transition zones of the prostate. It is believed that as these elements enlarge, the capsule surrounding the gland prevents it from expanding and results in?
compression of the urethra.
In addition, obstruction gradually leads to bladder dysfunction, which is believed to contribute significantly to symptoms, including increased urinary frequency and urgency, nocturia, difficulty initiating a stream, a weak stream, and incomplete bladder emptying. Smooth muscle proliferation within the prostate and tension in the stroma, urethra, and bladder neck all contribute to symptoms.
Because tension is mediated by a1-adrenergic receptors, the first-line treatment is a selective α1-receptor blocker such as?
tamsulosin. In fact, the α1a subtype of receptors is the most concentrated in the bladder neck and prostate, and tamsulosin is a partially selective α1a-blocker.